That contract was not renewed if there was nothing being developed. Ther are numerous trials in process with Novartis that are combinatorial in nature. There should be some progress reported by year end and a shot of revenues to back it up. The pipeline is bigger than what is on their website.
Cowboy, try this. NVS is using a min of three diffrent HTS platforms. It is possible that some of the combo trials are cHTS related but how many is an open question. The pipeline is NVS's as per the agreement but if ZLCS is involved in any of them, they will reap rewards if any move into late P's or market. Odds favor some of the P's being Z related but how many and to what end... we will not know until an 8k hits the wires. Steeling is correct that the relationship between the two has a longer than intitally expected, and if it were not producing it would have been terminated.